A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST) Meeting Abstract

  

Authors:	Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; Yoon, S. S.; Ulaner, G. A.; Martindale, M.; Condy, M. M.; Phelan, H.; Biniakewitz, M.; Singer, S.; Hwang, S.; Antonescu, C. R.; Tap, W. D.
Abstract Title:	A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
Meeting Title:	56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	38
Issue:	15 Suppl.
Meeting Dates:	2020 May 29-31
Meeting Location:	Virtual
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2020-05-20
Start Page:	552s
Language:	English
ACCESSION:	WOS:000560368300369
PROVIDER:	wos
DOI:	10.1200/JCO.2020.38.15_suppl.11508
Notes:	Meeting Abstract: 11508 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/172841